Since cancer is a leading cause of death worldwide, and the low efficacy of many existing therapies is a major clinical challenge, it is essential to understand the prognostic and immunological impact of IGF-1 and IGF-1R among cancer types comprehensively in order to develop novel immunotherapies. The gene discussed is IGF1R; the disease is cancer.